Uprosertib has been used in trials studying the treatment of Cancer, Melanoma, Solid Tumours, Cervical Cancer, and HER2/Neu Negative, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.